Medical Devices stocks worldwide, ranked

As of 13 Nov 2026, T&L (340570.KQ) ranks first in Medical Devices on MoatMap, with a MoatMap Score of 99/100, among 167 companies in 17 countries worth $200M or more that trade $1M or more a day. A research ranking, not investment advice.

The score reads each company's latest yearly results, so when a whole industry is near the top of its cycle, its companies can rank high together.

Live list, follows each night's scores · scores as of ·How we score stocks

The top 25 Medical Devices companies by MoatMap Score

#StockYieldP/EScoreQVMStyle · Activity
1
340570.KQ
T&L Co., Ltd.
South Korea · $292.4M

Quality 87: wide operating margins and ROIC in the top 5% of its sector. Value 79: cheap on EV/EBITDA and cheap on P/E. Momentum 58: quarterly earnings growing.

Yield 3.2%P/E 9.9
99
Score
87
Q
79
V
58
M
Full HouseDeep dive →
2
7575.T
Japan Lifeline Co., Ltd.
Japan · $707.7M

Quality 76: interest well covered and ROIC in the top 10% of its sector. Value 71: cheap on P/E and cheap on EV/EBITDA. Momentum 67: near its 52-week high and outperforming the market over 6 months.

Yield 3.2%P/E 12.7
98
Score
76
Q
71
V
67
M
Full House
3
4736.TW
TaiDoc Technology Corporation
Taiwan · $418.2M

Value 74: cheap on P/E and a high yield. Quality 71: ROIC in the top 5% of its sector and high return on equity. Momentum 68: near its 52-week high and quarterly earnings growing.

Yield 3.6%P/E 5.2
98
Score
71
Q
74
V
68
M
Full House
4
DRW3.DE
Drägerwerk AG & Co. KGaA
Germany · $2.1B

Value 82: cheap on sales and cheap on EV/EBITDA. Quality 72: F-Score 9/9 and high gross profitability. Momentum 58: above its moving averages but estimates cut.

Yield 2.2%P/E 11.4
97
Score
72
Q
82
V
58
M
Full House
5
6823.T
Rion Co., Ltd.
Japan · $254.8M

Value 84: cheap on EV/EBITDA and below book value. Quality 79: low debt and interest well covered. Momentum 48: estimates revised up but estimates cut.

Yield 3.3%P/E 11.4
97
Score
79
Q
84
V
48
M
Unloved QualityDeep dive →
6
1789.HK
AK Medical Holdings Limited
China · $592.4M

Quality 78: F-Score 8/9 and wide operating margins. Value 74: cheap on EV/EBITDA and cheap on P/E. Momentum 50: estimates revised up but below its moving averages.

Yield 2.5%P/E 12.4
95
Score
78
Q
74
V
50
M
Full HouseDir. buy $130KDeep dive →
7
6869.T
Sysmex Corporation
Japan · $7.4B

Momentum 80: outperforming the market over 6 months and above its moving averages. Quality 68: strong free cash flow and high gross profitability. Value 51: mixed.

Yield 1.8%P/E 32.4
93
Score
68
Q
51
V
80
M
Full House
8
6960.T
Fukuda Denshi Co., Ltd.
Japan · $1.8B

Quality 74: interest well covered and low debt. Value 69: cheap on EV/EBITDA and below book value. Momentum 55: above its moving averages but EPS deteriorating.

Yield 1.6%P/E 14.5
93
Score
74
Q
69
V
55
M
Full House
9
SNT.WA
Synektik Spólka Akcyjna
Poland · $726M

Quality 82: high return on equity and ROIC in the top 5% of its sector. Momentum 62: quarterly earnings growing and above its moving averages. Value 55: a high yield but far above book value.

Yield 3.3%P/E 15.8
93
Score
82
Q
55
V
62
M
Full HouseDeep dive →
10
INMD
InMode Ltd.
Israel · $803.9M

Value 77: cheap on EV/EBITDA and cheap on P/E. Quality 74: interest well covered and strong free cash flow. Momentum 46: quarterly earnings shrinking.

Yield —P/E 11.0
92
Score
74
Q
77
V
46
M
Unloved Quality
11
603387.SS
Getein Biotech, Inc
China · $677.5M

Value 69: a high yield and cheap on EV/EBITDA. Quality 67: wide operating margins and F-Score 7/9. Momentum 60: above its moving averages.

Yield 3.4%P/E 14.7
92
Score
67
Q
69
V
60
M
Full House
12
300832.SZ
Shenzhen New Industries Biomedical Engineering Co., Ltd.
China · $6.7B

Quality 83: wide operating margins and low debt. Momentum 76: estimates revised up and outperforming the market over 6 months. Value 35: expensive on sales.

Yield 2.0%P/E 26.3
91
Score
83
Q
35
V
76
M
Premium GrowerDir. buy $278K
13
6523.T
PHC Holdings Corporation
Japan · $1B

Value 81: cheap on sales and cheap on free cash flow. Momentum 63: above its moving averages and outperforming the market over 6 months. Quality 51: strong free cash flow but high debt.

Yield 2.9%P/E 18.6
91
Score
51
Q
81
V
63
M
Full House
14
6849.T
Nihon Kohden Corporation
Japan · $1.6B

Quality 70: interest well covered and high gross profitability. Value 65: cheap on sales and below book value. Momentum 58: estimates revised up but estimates cut.

Yield 1.9%P/E 18.8
90
Score
70
Q
65
V
58
M
Full House
15
CNMD
CONMED Corporation
United States · $1.5B

Momentum 74: quarterly earnings growing and outperforming the market over 6 months. Value 64: cheap on sales and cheap on free cash flow. Quality 55: strong free cash flow but high debt.

Yield —P/E 21.4
90
Score
55
Q
64
V
74
M
Full House
16
TCMD
Tactile Systems Technology, Inc.
United States · $535.5M

Quality 83: high gross profitability and F-Score 8/9. Momentum 55: estimates revised up but estimates cut. Value 54: cheap on free cash flow.

Yield —P/E 25.3
90
Score
83
Q
54
V
55
M
Full HouseDir. sell $578K
17
VMD
Viemed Healthcare, Inc.
United States · $373.3M

Quality 76: high gross profitability and strong free cash flow. Value 65: cheap on EV/EBITDA and cheap on sales. Momentum 51: EPS deteriorating.

Yield —P/E 24.0
90
Score
76
Q
65
V
51
M
Full HouseDir. sell $347K
18
4543.T
Terumo Corporation
Japan · $22.6B

Momentum 71: near its 52-week high and outperforming the market over 6 months. Quality 67: wide operating margins and interest well covered. Value 53: mixed.

Yield 1.1%P/E 22.4
89
Score
67
Q
53
V
71
M
Full House
19
GMED
Globus Medical, Inc.
United States · $10.9B

Quality 83: F-Score 8/9 and strong free cash flow. Value 62: cheap on free cash flow and cheap on EV/EBITDA. Momentum 45: estimates cut.

Yield —P/E 17.5
89
Score
83
Q
62
V
45
M
Unloved QualityDir. sell $6.9MDeep dive →
20
GETI-B.ST
Getinge AB (publ)
Sweden · $7.3B

Momentum 73: near its 52-week high and above its moving averages. Quality 65: F-Score 8/9 and strong free cash flow. Value 53: mixed.

Yield 1.7%P/E 26.7
89
Score
65
Q
53
V
73
M
Full HouseDir. buy $568KDeep dive →
21
688617.SS
APT Medical Inc.
China · $5.7B

Quality 93: ROIC in the top 5% of its sector and wide operating margins. Momentum 78: near its 52-week high and outperforming the market over 6 months. Value 20: far above book value.

Yield 0.4%P/E 39.3
89
Score
93
Q
20
V
78
M
Premium GrowerDir. sell $70.9M
22
603658.SS
Autobio Diagnostics Co., Ltd.
China · $3B

Quality 73: wide operating margins and low debt. Momentum 67: near its 52-week high and outperforming the market over 6 months. Value 50: a high yield.

Yield 3.3%P/E 21.5
89
Score
73
Q
50
V
67
M
Full House
23
2291.HK
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.
China · $610.7M

Quality 71: wide operating margins and low debt. Momentum 70: outperforming the market over 6 months and EPS improving. Value 49: a high yield but expensive on free cash flow.

Yield 4.0%P/E 21.6
89
Score
71
Q
49
V
70
M
Premium Grower
24
CHEMM.CO
ChemoMetec A/S
Denmark · $1.5B

Quality 92: F-Score 9/9 and wide operating margins. Momentum 84: outperforming the market over 6 months and estimates revised up. Value 14: far above book value.

Yield 1.0%P/E 60.9
88
Score
92
Q
14
V
84
M
Premium Grower
25
BVS
Bioventus Inc.
United States · $1B

Quality 72: F-Score 8/9 and high return on equity. Value 63: cheap on free cash flow and cheap on sales. Momentum 55: above its moving averages but estimates cut.

Yield —P/E 13.1
88
Score
72
Q
63
V
55
M
Full House

Ranked by MoatMap Score, the 0 to 100 score of Quality, Value and Momentum, among companies worth $200M or more that trade $1M or more a day, one line per company. Director dealings are director purchases and sales filed in the last 180 days, where MoatMap carries the market's filings.